Monospecific bivalent scFv-SH : Effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibilityALBRECHT, Huguette; DENARDO, Gerald L; DENARDO, Sally J et al.Journal of immunological methods. 2006, Vol 310, Num 1-2, pp 100-116, issn 0022-1759, 17 p.Article

Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapyHARTMANN SIANTAR, Christine L; DENARDO, Gerald L; DENARDO, Sally J et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 8, pp 1322-1329, issn 0161-5505, 8 p.Article

Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy : The role and option for dosimetry in clinical praticeDENARDO, Gerald L; HARTMANN SIANTAR, Christine L; DENARDO, Sally J et al.Cancer biotherapy & radiopharmaceuticals. 2002, Vol 17, Num 1, pp 107-118, issn 1084-9785Article

Treatment planning for molecular targeted radionuclide therapySIANTAR, Christine L; VETTER, Kai; DENARDO, Gerald L et al.Cancer biotherapy & radiopharmaceuticals. 2002, Vol 17, Num 3, pp 267-280, issn 1084-9785Article

Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting moleculesBURKE, Patricia. A; GREGG, Jeffrey P; BAKHTIAR, Brandon et al.International journal of oncology. 2006, Vol 29, Num 1, pp 49-55, issn 1019-6439, 7 p.Article

Characteristics of dimeric (bis) bidentate selective high affinity ligands as hHLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphomaDENARDO, Gerald L; HOK, Saphon; LEHMANN, Joerg et al.International journal of oncology. 2007, Vol 31, Num 4, pp 729-740, issn 1019-6439, 12 p.Article

Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and ⁹⁰Y-labeled HLD-DR antibodiesDENARDO, Gerald L; TOBIN, Evan; CHAN, Kaylund et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 7075s-7079s, issn 1078-0432, 2Conference Paper

Cilengitide targeting of α_vβ₃ integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenograftsBURKE, Patricia A; DENARDO, Sally J; MIERS, Laird A et al.Cancer research (Baltimore). 2002, Vol 62, Num 15, pp 4263-4272, issn 0008-5472Article

Combined modality radioimmunotherapy: Promise and perilBURKE, Patricia A; DENARDO, Sally J; MIERS, Laird A et al.Cancer. 2002, Vol 94, Num 4, pp 1320-1331, issn 0008-543X, SUPConference Paper

Radioimmunotherapy with ¹¹¹in/⁹⁰y-2it-BAD-m170 for metastatic prostate cancerO'DONNELL, Robert T; DENARDO, Sally J; MIRICK, Gary R et al.Clinical cancer research. 2001, Vol 7, Num 6, pp 1561-1568, issn 1078-0432Article

Metabolite production in patients with lymphoma after radiometal-labeled antibody administrationDENARDO, Gerald L; DENARDO, Sally J; KUKIS, David L et al.The Journal of nuclear medicine (1978). 2001, Vol 42, Num 9, pp 1324-1333, issn 0161-5505Article

Role of radiation dosimetry in radioimmunotherapy planning and treatment dosingDENARDO, Gerald L; JUWEID, Malik E; WHITE, Christine A et al.Critical reviews in oncology/hematology. 2001, Vol 39, Num 1-2, pp 203-218, issn 1040-8428Conference Paper

Development of TNKase specific cleavable peptide linked radioimmunoconjugates for radioimmunotherapyNATARAJAN, Arutselvan; KUMARESAN, Pappanaicken R; DENARDO, Sally J et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 17, pp 4802-4805, issn 0960-894X, 4 p.Article

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to lndium-111 /yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibodyRICHMAN, Carol M; DENARDO, Sally J; KUKIS, David L et al.Clinical cancer research. 2005, Vol 11, Num 16, pp 5920-5927, issn 1078-0432, 8 p.Article

Development of tumor targeting bioprobes (¹¹¹In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapyDENARDO, Sally J; DENARDO, Gerald L; MIERS, Laird A et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 7087s-7092s, issn 1078-0432, 2Conference Paper

Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancerIVKOV, Robert; DENARDO, Sally J; DAUM, Wolfgang et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 7093s-7103s, issn 1078-0432, 2Conference Paper

Enhancement of the therapeutic index : From non myeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancerDENARDO, Sally J; RICHMAN, Carol M; ALBRECHT, Huguette et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 7187s-7194s, issn 1078-0432, 2Conference Paper

Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of ⁹⁰Y-DOTA-peptide-Lym-1 in lymphoma xenograftsTUSCANO, Joseph M; O'DONNELL, Robert T; MIERS, Laird A et al.Blood. 2003, Vol 101, Num 9, pp 3641-3647, issn 0006-4971, 7 p.Article

Human antiglobulin response to foreign antibodies: therapeutic benefit?DENARDO, Gerald L; BRADT, Bonnie M; MIRICK, Gary R et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 5, pp 309-316, issn 0340-7004, 8 p.Article